News Wire
Pfizer Canada Recall: Some EpiPen and EpiPen Jr Auto-Injectors May Be Difficult to Remove...
Consumers and pharmacists in Canada should check that devices can be removed from their carrier tubes with ease.
Food Allergy Fund Summit: November 14 – Washington DC
Join us for a day of learning, raising awareness, and funding research on November 14th at the Newseum in Washington, DC.
Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support US Approval of...
Nasal Spray Product is Disruptive Innovation for People at Risk of Anaphylaxis.
Mylan to Pay $30 Million for Disclosure and Accounting Failure Relating to EpiPen
Mylan agreed to pay $30 million to settle charges they overcharged Medicaid hundreds of millions of dollars for EpiPen.
AAAAI Addresses What Patients and Their Families Need to Know About Oral Immunotherapy (OIT)
As the FDA moves closer to approving the first food allergy treatment, the AAAAI seeks to help patients and their families understand the realities surrounding OIT.
Coconut Coalition Launches Initiative to Remove Coconut From the FDA ‘Top 8’ Allergen List
CCA will request that FDA revise FALCPA guidance to remove coconut from the list of tree nuts.
Study: Few People with Peanut Allergy Tolerate Peanut after Stopping OIT
Continuing with a modest dose confers more protection, NIH-funded study finds.
Governor Cuomo Signs “Elijah’s Law” Requiring Child Care Providers to Follow Guidelines for Preventing...
Legislation introduces much needed protections to early child care programs.
Natasha’s Legacy Becomes Law in the UK
The new legislation, known as ‘Natasha’s Law’, covers foods that are prepared and packed on the same premises from which they are sold.
New Peanut Allergy Treatment Passes Phase 2 Trial, Shows Effectiveness and Safety
UNC School of Medicine researchers show that tiny under-the-tongue doses of peanut protein can offer safe and substantial protection against peanut allergy.
